首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1741521

抗辐射药物市场按适应症、给药途径、分销管道和地区划分

Anti-Radiation Drugs Market, By Indication, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

抗辐射药物市场规模预计在 2025 年为 6.695 亿美元，预计在 2032 年将达到 10.611 亿美元，2025 年至 2032 年的复合年增长率为 6.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	6.695亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	6.80%	2032年价值预测	10.611亿美元

抗辐射药物是用来抵抗辐射对人体有害影响的药物。长期暴露于电离辐射会对人体产生有害影响，并导致各种健康问题，包括放射病、癌症和基因突变，因此近年来对抗辐射药物的需求增加。

这些药物的作用原理是保护人体细胞和DNA免受辐射的有害影响。抗辐射药物可以降低辐射诱发疾病的风险，并提高辐射暴露者的存活率。对于在辐射暴露行业工作的人员以及居住在易受天然辐射影响地区的人们，抗辐射药物可以作为预防措施。

市场动态：

全球抗辐射药物市场预计在不久的将来将出现显着成长。市场成长的驱动力在于癌症发生率的上升以及放射线治疗在癌症治疗中的日益普及。核能发电厂数量的增加，以及潜在的辐射洩漏风险，将进一步刺激抗辐射药物的需求。

还有一些因素限制市场的成长，例如抗辐射药物成本高、药物审批的监管要求严格等。此外，医疗专业人员和一般民众对抗辐射药物的可用性和益处的认识较低也可能阻碍市场的成长。

儘管面临挑战，市场仍蕴含着巨大的成长机会。加大研发投入，开发新型改良型抗辐射药物，预计将为市场带来机会。个人化医疗需求的不断增长以及对精准医疗的日益关注，预计将推动市场成长。

本研究的主要特点

本报告对全球抗辐射药物市场进行了详细分析，包括预测期 2025-2032 的市场规模和复合年增长率（以 2024 年为基准年）。
它强调了各个细分市场中的潜在商机并说明了有吸引力的投资提案。
它提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
全球抗辐射药物市场的主要企业根据公司亮点、产品系列、财务表现和策略等参数进行分析。
本报告的见解将帮助负责人和经营团队就产品发布、升级、市场扩张和行销策略做出明智的决策。
本报告针对产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以从分析全球抗辐射药物市场所使用的各种策略矩阵中受益，从而促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 669.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.80%	2032 Value Projection:	USD 1,061.1 Mn

Anti-radiation drugs are pharmaceutical medications that are used to combat the harmful effects of radiation exposure in humans. Prolonged exposure to ionizing radiation can have detrimental effects on the body that leads to various health issues such as radiation sickness, cancer, and genetic mutations, and this has boosted demand for anti-radiation drugs in recent years.

These drugs work by protecting the body's cells and DNA from the damaging effects of radiation. These aid in reducing the risk of radiation-induced illnesses and improving the chances of survival for individuals exposed to radiation. Anti-radiation drugs can be used as preventive measures for people working in industries that involve radiation exposure, as well as for individuals in areas prone to natural radiation.

Market Dynamics:

Global anti-radiation drugs market is projected to witness significant growth in the near future. The market growth is driven by increasing prevalence of cancer and growing adoption of radiation therapy in cancer treatment. Rising number of nuclear power plants, along with the potential risk of radiation leaks, further boosts demand for anti-radiation drugs.

There are certain factors that may restrain the market growth. These include the high cost of anti-radiation drugs and the stringent regulatory requirements for drug approval. Moreover, the lack of awareness about the availability and benefits of these drugs among healthcare professionals and the general population could hinder market growth.

Despite the challenges, the market presents numerous opportunities for growth. Increasing investment in research and development activities to develop new and improved anti-radiation drugs expected to offer opportunity to the market. Rising demand for personalized medicine and growing focus on precision healthcare are expected to drive the market growth.

Key Features of the Study:

This report provides in-depth analysis of the global anti-radiation drugs market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year
It elucidates potential revenue opportunities across different market segments and explains attractive investment propositions
The study provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and the competitive strategies adopted by key players
Key players in the global anti-radiation drugs market are profiled based on parameters such as company highlights, product portfolio, financial performance, and strategies
The report includes prominent companies such as Amgen Inc., Partner Therapeutics Inc., RedHill Biopharma Ltd., Humanetics Corporation, RxBio Inc., Soligenix Inc., Aeolus Pharmaceuticals, Onconova Therapeutics, and Genome Protection Inc.
Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing tactics
The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders can benefit from the various strategy matrices used in analyzing the global anti-radiation drugs market, facilitating ease in decision-making

Anti-Radiation Drugs Market Detailed Segmentation:

By Indication:
- Acute Radiation Syndrome
- Delayed Radiation Syndrome
By Route of Administration:
- Oral
- Intramuscular
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Amgen Inc.
- Partner Therapeutics Inc.
- RedHill Biopharma Ltd.
- Humanetics Corporation
- RxBio Inc.
- Soligenix Inc.
- Aeolus Pharmaceuticals
- Onconova Therapeutics
- Genome Protection Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing incidence of cancer globally
Growing threat of nuclear accidents and events
Favorable regulatory environment for drug development
Technological advancements in drug delivery systems
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Anti-Radiation Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Anti-Radiation Drugs Market, By Indication, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Acute Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Delayed Radiation Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Global Anti-Radiation Drugs Market, By Route of Administration, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Global Anti-Radiation Drugs Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Global Anti-Radiation Drugs Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Partner Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RedHill Biopharma Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Humanetics Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
RxBio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Soligenix Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aeolus Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Onconova Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genome Protection Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

抗辐射药物市场按适应症、给药途径、分销管道和地区划分